Cardiogenesis Corp (CGCP:US)
was acquired by CRY:US
Cardiogenesis Corporation is a medical device company specializing in the treatment of cardiovascular disease. The Company's Holmium YAG laser system and fiber-optic accessories are used to perform a surgical procedure, known as transmyocardial revascularization (TMR), to treat patients suffering from angina. The TMR procedure is marketed in the United States, Europe, and Asia.